CAS: 656820-32-5; N6-Cyclohexyl-N2-(4-Morpholinophenyl)-9H-Purine-2,6-Diamine

该化合物是一个小分子,在生物医学研究领域,特别是生物医学和干细胞生物学的潜在应用方面引起了注意,众所周知,它有选择地抑制某些在包括扩散和差异在内的各种细胞过程中起着关键作用的动脉酶.对Reversine进行了研究,以了解其是否有能力导致成熟细胞的分化,从而使它们恢复到一个对组织工程和再生疗法具有重要意义的多功能状态.该化合物的分子重量相对较低,其特点是其特定的化学结构,其中包括一种像纯净的软骨架.其行动机制包括调整对细胞命运决定至关重要的信号路径.虽然很有希望,但还需要进一步研究,以充分了解其影响,优化其使用,并评估其在临床应用中的安全和功效.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

N6-Cyclohexyl-2-Fluoroadenine 852231-88-0
2-Chloro-N-Cyclohexyl-9H-Purin-6-Amine 39639-45-7

合成工艺路线路线简述

    📜2-氟-6-氯嘌呤置于n,N-二异丙基乙胺体系中,用 乙醇,正丁醇 作为反应溶剂,化学反应 36.0H,反应生成 N6-环己基-N2-(4-吗啉苯基)-9H-嘌呤-2,6-二胺
    参考文献:Dedifferentiation Of Lineage-Committed Cells By A Small Molecule
    标题:Dedifferentiation Of Lineage-Committed Cells By A Small Molecule
    摘要:Combinatorial Libraries Were Screened For Molecules That Induce Mouse Myogenic Lineage Committed Cells To Dedifferentiate In Vitro. A 2,6-Disubstituted Purine,Reversine,Was Discovered That Induces Lineage Reversal Of C2C12 Cells To Become Multipotent Progenitor Cells Which Can Redifferentiate Into Osteoblasts And Adipocytes. This And Other Such Molecules Are Likely To Provide New Insights Into The Molecular Mechanisms That Control Cellular Dedifferentiation And May Ultimately Be Useful To In Vivo Stem Cell Biology And Therapy.
    DOI:10.1021/ja037390K

    海关参考信息

    专利信息


    专利号:US-9023385-B2
    优先权日:2011-06-01
    标题 :Pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and/or salt thereof for improving liver functioning
    发明人:LEE KA HO KENNETH; CHEN RUOHAN; HOU ZHIBO; PAN QUANWEI
    权利人:LEE KA HO KENNETH; CHEN RUOHAN; HOU ZHIBO; PAN QUANWEI; ZHANGZHOU PIEN TZE HUANG PHARM
    摘要:A method of treating a patient to improve liver functioning includes providing a drug composed of at least one of pharmaceutical 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and a pharmaceutically acceptable salt thereof; and administering the drug to the patient in a manner and dosage effective to improve liver functioning. The 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine can inhibit the activated hepatic stellate cells from synthesizing and expressing collagens and other extracellular matrix proteins including MMPs and TIMPs, and so it can inhibit liver fibrosis. In the liver, it can inhibit collagen synthesis and expression, and therefore reverse and treat hepatitis and liver cirrhosis effectively. Also discloses is a method for preparing drugs for treating infective hepatitis, non-infectious hepatitis, liver injury, liver cirrhosis, liver cancer and liver fibrosis, and improving t liver functioning, in which the compound and/or salt thereof is used optionally or in combination with a target molecule or carrier comprising a vitamin A-coupled liposome.

    专利号:US-2023271983-A1
    优先权日:2020-07-29
    标题 :Functionalized isonitriles and products, preparation and uses thereof
    发明人:SOTELO PÉREZ EDDY; AZUAJE GUERRERO JHONNY ALBERTO; MAJELLARO MARIA
    权利人:UNIV SANTIAGO COMPOSTELA
    摘要:The present invention relates to functionalized isonitrile compounds, formed by means of multicomponent environmentally friendly reactions, suitable for coupling to functional molecules such as biomolecules, APIs, chromophore and fluorophore molecules. The invention also relates to conjugates between said isonitrile compounds and functional molecules, which are useful in the synthesis of pharmaceutic drugs or tools, fluorescent molecules and labels, polymeric smart materials. The invention furthermore provides a kit for the in-vitro preparation of the functionalized isontrile compounds and conjugates. The invention also contemplates the medical use of said compounds and conjugates.

    专利号:CN-119530189-A
    优先权日:2024-11-22
    标 题 :Recombinant omega-aminotransferase catalyst, encoding gene thereof and application of recombinant omega-aminotransferase catalyst in catalytic synthesis of cyclohexylamine

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Qin HX, Yang J, Cui HK, Li SP, Zhang W, Ding XL, Xia YH. Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo. Cytotechnology. 2013 Aug;65(4):643-53. doi: 10.1007/s10616-012-9520-8. Epub 2013 Mar 10.
    2: Lu CH, Liu YW, Hua SC, Yu HI, Chang YP, Lee YR. Autophagy induction of reversine on human follicular thyroid cancer cells. Biomed Pharmacother. 2012 Dec;66(8):642-7. doi: 10.1016/j.biopha.2012.08.001. Epub 2012 Sep 15. Review. Chinese. doi: 10.1002/jcb.24296. doi: 10.1002/jcb.24197. doi: 10.4161/cc.20621. Epub 2012 Jun 1. doi: 10.1007/s11095-012-0727-3. Epub 2012 Apr 4. doi: 10.1186/1423-0127-19-9.
    10: Conforti E, Arrigoni E, Piccoli M, Lopa S, de Girolamo L, Ibatici A, Di Matteo A, Tettamanti G, Brini AT, Anastasia L. Reversine increases multipotent human mesenchymal cells differentiation potential. J Biol Regul Homeost Agents. 2011 Apr-Jun;25(2 Suppl):S25-33.

    合成参考文献


    参考文献:10.1038/ncomms1319
    摘要:Saurin AT, van der Waal MS, Medema RH, Lens SMA, Kops GJPL. Aurora B potentiates Mps1 activation to ensure rapid checkpoint establishment at the onset of mitosis. Nature Communications. 2011 May 17;2(1):316. doi: 10.1038/ncomms1319.
    参考文献:10.1186/s12935-019-0885-z
    摘要:Huang D, Huang Y, Huang Z, Weng J, Zhang S, Gu W. Relation of AURKB over-expression to low survival rate in BCRA and reversine-modulated aurora B kinase in breast cancer cell lines. Cancer Cell International. 2019 Jun 18;19(1):166. doi: 10.1186/s12935-019-0885-z.
    参考文献:10.1038/s41388-019-0851-1
    摘要:Guo Y, Zhang X, Xu Q, Gong F, Shi X, Li C, Huang R, Nie F, Zhu W, Li J, Tang J, Li R, Zhang L, Chen L, Ma RZ. Human Papillomavirus 16 oncoprotein E7 retards mitotic progression by blocking Mps1-MAP4 signaling cascade. Oncogene. 2019 Aug;38(31):5959–70. doi: 10.1038/s41388-019-0851-1.
    参考文献:10.1021/ja037390k
    摘要:Chen S, Zhang Q, Wu X, Schultz PG, Ding S. Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc. 2004 Jan 21;126(2):410–1. doi: 10.1021/ja037390k.
    参考文献:10.1002/anie.200460346
    摘要:Gey C, Giannis A. Small molecules, big plans--can low-molecular-weight compounds control human regeneration Angew Chem Int Ed Engl. 2004 Aug 06;43(31):3998–4000. doi: 10.1002/anie.200460346.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知